It is a food and beverages private limited company based in Mumbai, Maharashtra, India, established in 2018.
2018 | Mumbai, Maharashtra, India | ActiveProtota Pharmaceuticals Private Limited, a active private limited company, was established on 05 October 2018 in Mumbai, Maharashtra, India. Engaging in manufacturing within the food and beverages sector, it holds CIN: U24304MH2018PTC315326. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Meena Surinder Dang (Director), Surinder Dang (Director), Anmol Surinder Dang (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 601 Sanctura Wing, Senroof Projects, Off Goregaon Mulund Link Road, Mulund (E), Mumbai, Maharashtra, 400081.
U24304MH2018PTC315326
315326
05 October 2018
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Protota Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meena Surinder Dang | Director | 05 Oct 2018 | Current |
| Surinder Dang | Director | 05 Oct 2018 | Current |
| Anmol Surinder Dang | Director | 05 Oct 2018 | Current |
| Charchit Surinder Dang | Director | 05 Oct 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Protota Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 1.44% increase in profit. The company's net worth dipped by a decrease of 0.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Protota Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Protota Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Protota Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Protota Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Protota Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Protota Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Meena Surinder Dang was appointed as a Director was appointed as a Director on 05 Oct 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.
Surinder Dang was appointed as a Director was appointed as a Director on 05 Oct 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.
Progress on Anmol Surinder Dang was appointed as a Director was appointed as a Director on 05 Oct 2018 & has been associated with this company since 7 years 2 months . was documented.
Progress on Charchit Surinder Dang was appointed as a Director was appointed as a Director on 05 Oct 2018 & has been associated with this company since 7 years 2 months . was documented.
The CIN of Protota Pharmaceuticals Private Limited is U24304MH2018PTC315326.
Protota Pharmaceuticals Private Limited is headquartered at 601 Sanctura Wing, Senroof Projects, Off Goregaon Mulund Link Road, Mulund (E), Mumbai, Maharashtra, 400081.
Protota Pharmaceuticals Private Limited was incorporated on 05 October 2018.
The current directors of Protota Pharmaceuticals Private Limited are
The primary industry of Protota Pharmaceuticals Private Limited is Food And Beverages.
Protota Pharmaceuticals Private Limited is unlisted.
The authorized capital of Protota Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX